• Skip to content
  • Skip to footer

Consortia Therapeutics

Food Allergies and the Human Gut Microbiome

  • About
    • Blog
    • In the News
    • Press Releases
  • Our Team
  • The Science
    • The Human Microbiome
    • Products
    • Related Research
    • Dictionary
  • FAQs
  • Contact Us

Products

Our Solution

Functional analyses have identified human-origin commensal bacteria that promote tolerant responses in the immune system that prevent or can reverse food allergies. Our team has identified specific strains and their mechanisms of action that promote these effects. We have developed two protective consortia and a third that promotes the development of allergic responses. This third consortium is providing biomarkers and further mechanistic understanding of the dysbiosis that contributes to the development of food allergies.

  • Gut-Protect I: Defined flora with treat-to-prevent and treat-to-cure activities, obligately anaerobic consortium with no tolerance for the presence of oxygen
  • Gut-Protect II: Defined flora with treat-to-prevent activities and better tolerance to the presence of oxygen.
  • Negative Control Consortium (NCC): Defined species that skew the immune system from tolerance to allergy.

Footer

Contact Us

Send us a message

Address:
ConsortiaTX, Inc.
Suite 206
2223 Avenida de la Playa
La Jolla CA 92037

Consortia Therapeutics develops microbial therapies to prevent and treat human disease.

Our work is based upon evidence-based studies from the Massachusetts Host Microbiome Center and the research of it’s scientific founders.

Consortia Therapeutics
  • ConsortiaTX
  • About
  • Our Team
  • The Science
  • FAQs
  • Contact Us

Copyright © 2019 · Consortia Therapeutics